Larvol Delta - ASPIRO-TRIAL--TWELVEMONTH-SAFETY-TOLERABILITY-AND-EFFICACY-OF-INTRACRANIAL-DELIVERY-OF-AUTOLOGOUS-IPSCDERIVED-DOPAMINERGIC-PRECURSORS-SASINEPROCEL-IN-MODERATE-TO-ADVANCED-PARKINSON39S-DISEASE

sasineprocel (ANPD001) - Aspen Neurosci

Avram Fraint; Paul Larson; Chadwick Christine; Nicolas Phielipp; Melissa Houser; Scott Sherman; Edward Wirth

Jan 10, 2026